any thought comments ect

Eugene Kopp
Executive Chairman
BEcon, MBA
Mr Eugene Kopp, aged 44, was appointed as a non-executive director on 17 June, 2004 and became Chairman in October 2004. Mr Kopp is Managing Director of private equity company, Bluscan Pty Ltd, which invests in private and listed companies focusing on emerging technologies and turn around opportunities. He currently holds non-executive directorship in Convé Plc, a London based Australian pharmaceutical company focussed on anti-fungal treatments. He has 20 years’ experience in merchant banking and four years of experience of direct relevance to the biotechnology sector. He was with investment bank Deutsche Morgan Grenfell for five years based in London and Moscow as associate director of corporate finance.


Previously, he was director of ANZ Investment Bank, heading up its Project Finance Advisory group in Australia and New Zealand. He has a Bachelor of Economics and Politics from Monash University Melbourne, and an MBA from IMD in Switzerland. He is a graduate member of the Australian Institute of Directors.


Mr Kopp is also the Chairman of the Audit Committee and Remuneration Committee.

Well I would say turn around oppurtunity sums this up